News
Recent research highlights the potential of non-psychoactive cannabinoids—CBD, CBG, and CBN—as promising therapeutic tools for Autism Spectrum Disorder (ASD). CBD has shown efficacy in reducing anxiety, aggression, and sleep disturbances, while CBG may support cognitive function and reduce neuroinflammation. CBN, often associated with sleep improvement, is also being studied for its neurogenic properties. The most significant benefits appear when these compounds work together in full-spectrum formulations, leveraging the entourage effect to enhance symptom relief. While further large-scale studies are needed, these findings suggest that cannabinoids could play a transformative role in ASD treatment.
Understanding how your body absorbs cannabinoids like CBD, CBG, CBN, CBC, and THCA is key to unlocking their full potential. Factors like genetics, metabolism, and even your method of consumption impact how well these compounds work. While tinctures absorbed under the tongue boast high bioavailability (up to 75%), edibles lose much of their potency through digestion. High-potency topicals can penetrate all skin layers for long-term anti-inflammatory relief, while inhalation offers fast-acting effects. These cannabinoids interact with key receptors in the body—some of the same ones targeted by pharmaceuticals but without the harsh side effects. Ready to maximize your benefits? Choose the right method, pair it with food, and explore the power of full-spectrum products for optimal results.
